» Articles » PMID: 29805576

Effects of MiR-126 on the STAT3 Signaling Pathway and the Regulation of Malignant Behavior in Lung Cancer Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 May 29
PMID 29805576
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The functions of miR-126-mediated signal transducers and activators of the transcription 3 (STAT3) signal pathway were investigated in regulating the behavior of cells in non-small cell lung cancer (NSCLC). Cultured NSCLC A549 cells were transfected with empty, miR-126 overexpression or miR-126 knocked-down expression plasmids. After transfection efficiency verification by reverse transcription polymerase chain reaction (RT-PCR) and culture for 24 h, methyl thiazolyl tetrazolium (MTT) was applied to detect cell proliferation rate, migration distance was measured in scratch assays, cell cycle was determined through flow cytometry, the mRNA expression level of caspase-3 in cells was detected using RT-PCR and protein expression levels of STAT3 were detected using western blotting. Our results showed the cell proliferation rate was significantly higher in cells of the overexpression group than that in those of the control group (p<0.05) and the rate in the cells of the low-expression group was the lowest among the three groups (p<0.05). The migration distance of the overexpression group cells was significantly longer than that in the control group cells and the shortest migration distance was found in the low-expression group cells (p<0.05). The amount of cells in mitotic phase in the overexpression group was significantly higher than that in the control group and the same amount in the low-expression group was the lowest (p<0.05). The mRNA expression level of caspase-3 of cells in the overexpression group was significantly lower than that of cells in the control group and the highest expression level was found in the low-expression group (p<0.05). Finally, the protein expression levels of STAT3 in cells in the overexpression group were significantly lower than those in the control group and the highest expression levels were identified in the low-expression group (p<0.05). Based on our findings, the cancer-promoting miR-126 can mediate the activation of the STAT3 signal pathway to regulate the malignant biological behavior of NSCLC cells affecting their proliferation, migration, cycle and apoptosis susceptibility.

Citing Articles

Circulating microRNAs as a Prognostic Tool to Determine Treatment Efficacy in Lung Cancer Patients Undergoing Pembrolizumab PD-1 Blockade Immunotherapy.

Mohamed Mansoor M, Zhu X, Ashiqueali S, Alam M, Winiarska H, Pazdrowski P Cancers (Basel). 2025; 16(24.

PMID: 39766101 PMC: 11674096. DOI: 10.3390/cancers16244202.


Integrative Biomarker Panel for Improved Lung Cancer Diagnosis Using Plasma microRNAs and Sputum Bacterial DNA.

Dhilipkannah P, Sachdeva A, Holden V, Jiang F Curr Oncol. 2024; 31(10):5949-5959.

PMID: 39451748 PMC: 11506187. DOI: 10.3390/curroncol31100444.


Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues.

Mehrzad N, Zamani M, Rahimi A, Shamaei M, Karimipoor M Iran Biomed J. 2024; 28(1):53-8.

PMID: 38445462 PMC: 10994634. DOI: 10.61186/ibj.3845.


Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions.

Moeinafshar A, Nouri M, Shokrollahi N, Masrour M, Behnam A, Tehrani Fateh S Cancer Cell Int. 2024; 24(1):26.

PMID: 38200584 PMC: 10782702. DOI: 10.1186/s12935-023-03203-2.


Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review).

Ma R, Ma C, Hu K, Zhao M, Zhang N, Sun Z Int J Oncol. 2022; 61(3).

PMID: 35856449 PMC: 9339493. DOI: 10.3892/ijo.2022.5395.


References
1.
Hou J, Meng F, Chan L, Cho W, Wong S . Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC. Front Genet. 2016; 7:193. PMC: 5093122. DOI: 10.3389/fgene.2016.00193. View

2.
Yang J, Lan H, Huang X, Liu B, Tong Y . MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. PLoS One. 2012; 7(8):e42978. PMC: 3416793. DOI: 10.1371/journal.pone.0042978. View

3.
Lo H, Cao X, Zhu H, Ali-Osman F . Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res. 2010; 8(2):232-45. PMC: 2824777. DOI: 10.1158/1541-7786.MCR-09-0391. View

4.
Yu Z, Willmarth N, Zhou J, Katiyar S, Wang M, Liu Y . microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A. 2010; 107(18):8231-6. PMC: 2889540. DOI: 10.1073/pnas.1002080107. View

5.
Yin Z, Zhang Y, Li Y, Lv T, Liu J, Wang X . Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Acta Histochem. 2011; 114(2):151-8. DOI: 10.1016/j.acthis.2011.04.002. View